Sinus bradycardia causes: Difference between revisions
(16 intermediate revisions by 3 users not shown) | |||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Sinus bradycardia does not necessarily refer to the presence of an obvious pathology; in fact, it may occur in normal, healthy individuals including well-trained [[athletes]], some [[elderly]] people or during [[sleep]]. It may also be due to an exaggerated response to normal physiological processes (e.g. [[vomiting]], [[coughing]], [[defecation]]) or from pathologies involving the [[SA node]] such as [[sick sinus syndrome]], [[myocardial infarction]]. The most common medications causing sinus bradycardia are [[beta blockers]], [[digitalis]] and [[calcium channel blockers]]. However, life-threatening conditions including chemical [[poisoning]] ([[organophosphate]], [[sarin]]), [[sepsis]], [[electrolyte imbalance]] should be promptly recognized and treated. | |||
==Causes== | ==Causes== | ||
===Life Threatening Causes=== | ===Life Threatening Causes=== | ||
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. | |||
*[[Beta blockers#Adverse effects|Beta blocker overdose]] | |||
*[[Carbamate|Carbamate poisoning]] | |||
*[[Cervical spine injury]] | |||
*[[Digitalis toxicity]] | |||
*[[Drowning]] | |||
*[[Electric shock]] | |||
*[[Electrolyte imbalance]] | |||
*[[Hypoglycemia]] | |||
*[[Intracranial pressure#Increased ICP|Increased intracranial pressure]] | |||
*[[Lily of the Valley|Lily of the valley poisoning]] | |||
*[[Lithium toxicity]] | |||
*[[Myocardial infarction]] | |||
*[[Nerve agent|Nerve agent poisoning]] e.g. [[sarin]] | |||
*[[Organophosphate poisoning]] | |||
*[[Rabies]] | |||
*[[Sepsis]] | |||
===Common Causes=== | ===Common Causes=== | ||
*[[Aging]] | |||
*[[Beta blocker]] | |||
*[[Calcium channel blocker]] | |||
*[[Cardiac catheterization]] | |||
*[[Electrolyte imbalance]] | |||
*[[Hypothermia]] | |||
*[[Hypothyroidism]] | |||
*[[Myocardial infarction]] | |||
*[[Nausea]] | |||
*[[Obstructive sleep apnea]] | |||
*[[Sedative]] | |||
*[[Sepsis]] | |||
*[[Sleep]] | |||
*[[Sick sinus syndrome]] | |||
===Causes by Organ System=== | ===Causes by Organ System=== | ||
{|style="width: | {|style="width:75%; height:100px" border="1" | ||
|style="height:100px"; style="width:25%" border="1" bgcolor="LightSteelBlue" |'''Cardiovascular''' | |style="height:100px"; style="width:25%" border="1" bgcolor="LightSteelBlue" |'''Cardiovascular''' | ||
|style="height:100px"; style="width:75%" border="1" bgcolor="Beige" | [[Carotid sinus hypersensitivity ]], [[endocarditis ]], [[hypertrophic cardiomyopathy]], [[left ventricular noncompaction]], [[LQT4|LQT4 mutation]], [[myocardial infarction]], [[myocarditis]], [[pericarditis]], [[sick sinus syndrome]], [[vasovagal syncope]] | |style="height:100px"; style="width:75%" border="1" bgcolor="Beige" | [[Carotid sinus hypersensitivity]], [[endocarditis]], [[hypertrophic cardiomyopathy]], [[left ventricular noncompaction]], [[LQT4|LQT4 mutation]], [[myocardial infarction]], [[myocarditis]], [[pericarditis]], [[sick sinus syndrome]], [[vasovagal syncope]] | ||
|- | |- | ||
|bgcolor="LightSteelBlue"| '''Chemical/Poisoning''' | |bgcolor="LightSteelBlue"| '''Chemical/Poisoning''' | ||
Line 29: | Line 61: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Drug Side Effect''' | | '''Drug Side Effect''' | ||
|bgcolor="Beige"| [[Adenosine]], [[alfentanil]], [[ambenonium]], [[amiodarone]], [[atenolol]], [[bethanechol]], [[bupivacaine]], [[calcium channel blocker]], [[celecoxib]], [[cilobradine]],<ref name="van bogaert-2003">{{cite journal | last1 = van bogaert | first1 = pp. | last2 = pittoors | first2 = f. | title = use-dependent blockade of cardiac pacemaker current (if) by cilobradine and zatebradine. | journal = eur j pharmacol | volume = 478 | issue = 2-3 | pages = 161-71 | month = oct | year = 2003 | doi = | pmid = 14575801 }}</ref> [[citalopram]], [[clonidine]], [[deserpidine]], [[diltiazem]], [[dimethyl sulfoxide]], [[distigmine]], [[dronedarone]], [[febuxostat]], [[fentanyl]],[[fingolimod]], [[flecainide]], [[fosphenytoin]], [[grayanotoxin]], [[guanethidine]], [[H2 receptor antagonist]], [[ivabradine]], [[lanreotide]], [[lidocaine ]], [[lofexidine]], [[mefloquine]], [[methyldopa]], [[mexiletine]], [[muscarine]], [[nadolol]], [[nefazodone]],[[neostigmine]], [[paclitaxel ]], [[palonosetron]], [[physostigmine ]], [[procainamide | |bgcolor="Beige"| [[Adenosine]], [[alfentanil]], [[ambenonium]], [[amiodarone]], [[atenolol]], [[bethanechol]], [[bupivacaine]], [[calcium channel blocker]], [[celecoxib]], [[cilobradine]],<ref name="van bogaert-2003">{{cite journal | last1 = van bogaert | first1 = pp. | last2 = pittoors | first2 = f. | title = use-dependent blockade of cardiac pacemaker current (if) by cilobradine and zatebradine. | journal = eur j pharmacol | volume = 478 | issue = 2-3 | pages = 161-71 | month = oct | year = 2003 | doi = | pmid = 14575801 }}</ref> [[citalopram]], [[clonidine]], [[deserpidine]], [[diltiazem]], [[dimethyl sulfoxide]], [[distigmine]], [[dronedarone]], [[febuxostat]], [[fentanyl]],[[fingolimod]], [[flecainide]], [[fosphenytoin]], [[grayanotoxin]], [[Granisetron]], [[guanethidine]], [[H2 receptor antagonist]], [[ivabradine]], [[lanreotide]], [[lidocaine]], [[lofexidine]], [[mefloquine]], [[methyldopa]], [[mexiletine]], [[muscarine]], [[nadolol]], [[nefazodone]],[[neostigmine]], [[octreotide]], [[paclitaxel]], [[palonosetron]], [[physostigmine]], [[procainamide]], [[propranolol]], [[quinidine]], [[rabeprazole]], [[regadenoson]], [[reserpine]], [[sedative]], [[somatostatin]], [[sotalol]], [[sufentanil]],[[suxamethonium]], [[toluene|toluene sniffing]], [[cocaine|topical cocaine]], [[verapamil]], [[veratridine|veratridine (false hellebore)]], [[zaleplon]], [[zatebradine]] <ref name="Van Bogaert-2003">{{Cite journal | last1 = Van Bogaert | first1 = PP. | last2 = Pittoors | first2 = F. | title = Use-dependent blockade of cardiac pacemaker current (If) by cilobradine and zatebradine. | journal = Eur J Pharmacol | volume = 478 | issue = 2-3 | pages = 161-71 | month = Oct | year = 2003 | doi = | PMID = 14575801 }}</ref> | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 37: | Line 69: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Endocrine''' | | '''Endocrine''' | ||
|bgcolor="Beige"| [[Cretinism ]], [[diabetic neuropathy]], [[hemochromatosis]], [[hypothyroidism]], [[tumor lysis syndrome]] | |bgcolor="Beige"| [[Cretinism]], [[diabetic neuropathy]], [[hemochromatosis]], [[hypothyroidism]], [[tumor lysis syndrome]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Environmental''' | | '''Environmental''' | ||
|bgcolor="Beige"| [[Altitude sickness]], [[decompression sickness ]], [[electric shock]], [[hypothermia]] | |bgcolor="Beige"| [[Altitude sickness]], [[decompression sickness]], [[electric shock]], [[hypothermia]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 50: | Line 82: | ||
| '''Genetic''' | | '''Genetic''' | ||
|bgcolor="Beige"| [[Arnold-Chiari malformation]], [[cretinism]], [[HCN4|HCN4 mutation]], [[hemochromatosis]], [[LQT4|LQT4 mutation]], [[myotonic dystrophy ]], [[Nav1.5|SCN5A mutation]] | |bgcolor="Beige"| [[Arnold-Chiari malformation]], [[cretinism]], [[HCN4|HCN4 mutation]], [[hemochromatosis]], [[LQT4|LQT4 mutation]], [[myotonic dystrophy ]], [[Nav1.5|SCN5A mutation]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Hematologic''' | | '''Hematologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Hemochromatosis]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Iatrogenic''' | | '''Iatrogenic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Cardiac catheterization]], [[cardiac transplantation]], [[Toluene|toluene sniffing]], [[transcatheter aortic valve implantation]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Infectious Disease''' | | '''Infectious Disease''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Babesiosis]], [[brucellosis]], [[Chagas disease]], [[dengue fever]], [[diptheria]], [[legionellosis]], [[leptospirosis ]], [[Lyme disease]], [[malaria]], [[meningitis ]], [[Q fever ]], [[rabies]], [[rheumatic fever]], [[rocky mountain spotted fever]], [[sepsis ]], [[trichinosis]], [[typhoid fever]], [[typhus]], [[viral hemorrhagic fever]], [[yellow fever]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Musculoskeletal/Orthopedic''' | | '''Musculoskeletal/Orthopedic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Myotonic dystrophy]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Neurologic''' | | '''Neurologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Cerebral edema]], [[diabetic neuropathy]], [[epilepsy]], [[Intracranial pressure#Increased ICP|increased intracranial pressure]], [[meningitis]], [[rabies]], [[subarachnoid hemorrhage]], [[vasovagal syncope]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Nutritional/Metabolic''' | | '''Nutritional/Metabolic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Hypoglycemia]], [[kwashiorkor]], [[sepsis]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Obstetric/Gynecologic''' | | '''Obstetric/Gynecologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Pregnancy]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 90: | Line 121: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Overdose/Toxicity''' | | '''Overdose/Toxicity''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Crizotinib|Crizotinib toxicity]], [[digitalis toxicity]], [[fluoxetine]], [[fluvoxamine]], [[Ibutilide|ibutilide toxicity]], [[lithium toxicity]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Psychiatric''' | | '''Psychiatric''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Anorexia nervosa]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Pulmonary''' | | '''Pulmonary''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Cough syncope]], [[drowning]], [[hypercapnia]], [[obstructive sleep apnea]], [[sarcoidosis]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Renal/Electrolyte''' | | '''Renal/Electrolyte''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Hypercalcemia]], [[hyperkalemia]], [[hypermagnesemia]], [[hypokalemia]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Rheumatology/Immunology/Allergy''' | | '''Rheumatology/Immunology/Allergy''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Amyloidosis]], [[neonatal lupus erythematosus]], [[rheumatoid arthritis]], [[sarcoidosis]], [[scleroderma]], [[systemic lupus erythematosus]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 114: | Line 145: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Trauma''' | | '''Trauma''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Cervical spine injury]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 122: | Line 153: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Miscellaneous''' | | '''Miscellaneous''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Aging]], [[altitude sickness]], [[decompression sickness]], [[defecation]], [[drowning]], [[micturition syncope]], [[nausea]], [[sleep]], [[starvation]], [[Physical exercise|trained athletes]], [[valsalva maneuver]], [[vomiting]] | ||
|- | |- | ||
|} | |} | ||
Line 275: | Line 306: | ||
*[[Yellow fever]] | *[[Yellow fever]] | ||
*[[Zaleplon]] | *[[Zaleplon]] | ||
* | *Zatebradine<ref name="Van Bogaert-2003">{{Cite journal | last1 = Van Bogaert | first1 = PP. | last2 = Pittoors | first2 = F. | title = Use-dependent blockade of cardiac pacemaker current (If) by cilobradine and zatebradine. | journal = Eur J Pharmacol | volume = 478 | issue = 2-3 | pages = 161-71 | month = Oct | year = 2003 | doi = | PMID = 14575801 }}</ref> | ||
{{col-end}} | {{col-end}} | ||
Latest revision as of 07:36, 3 February 2015
Sinus bradycardia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Sinus bradycardia causes On the Web |
American Roentgen Ray Society Images of Sinus bradycardia causes |
Risk calculators and risk factors for Sinus bradycardia causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ayokunle Olubaniyi, M.B,B.S [2]
Overview
Sinus bradycardia does not necessarily refer to the presence of an obvious pathology; in fact, it may occur in normal, healthy individuals including well-trained athletes, some elderly people or during sleep. It may also be due to an exaggerated response to normal physiological processes (e.g. vomiting, coughing, defecation) or from pathologies involving the SA node such as sick sinus syndrome, myocardial infarction. The most common medications causing sinus bradycardia are beta blockers, digitalis and calcium channel blockers. However, life-threatening conditions including chemical poisoning (organophosphate, sarin), sepsis, electrolyte imbalance should be promptly recognized and treated.
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
- Beta blocker overdose
- Carbamate poisoning
- Cervical spine injury
- Digitalis toxicity
- Drowning
- Electric shock
- Electrolyte imbalance
- Hypoglycemia
- Increased intracranial pressure
- Lily of the valley poisoning
- Lithium toxicity
- Myocardial infarction
- Nerve agent poisoning e.g. sarin
- Organophosphate poisoning
- Rabies
- Sepsis
Common Causes
- Aging
- Beta blocker
- Calcium channel blocker
- Cardiac catheterization
- Electrolyte imbalance
- Hypothermia
- Hypothyroidism
- Myocardial infarction
- Nausea
- Obstructive sleep apnea
- Sedative
- Sepsis
- Sleep
- Sick sinus syndrome
Causes by Organ System
Causes in Alphabetical Order
References
- ↑ van bogaert, pp.; pittoors, f. (2003). "use-dependent blockade of cardiac pacemaker current (if) by cilobradine and zatebradine". eur j pharmacol. 478 (2–3): 161–71. PMID 14575801. Unknown parameter
|month=
ignored (help) - ↑ 2.0 2.1 2.2 Van Bogaert, PP.; Pittoors, F. (2003). "Use-dependent blockade of cardiac pacemaker current (If) by cilobradine and zatebradine". Eur J Pharmacol. 478 (2–3): 161–71. PMID 14575801. Unknown parameter
|month=
ignored (help)